Last update :
19/11/2024
Anti-inflammatory   Piroxicam  
injection
Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Algoxam Italy
Alpex Iran
Ameroxicam Colombia
Artinor Mexico
Axtrim Mexico
Biopirox Venezuela
Brexivel Italy
Camrox India
Camsun India
Clinit Germany
Dekamega Spain
Dispercam Egypt, Saudi Arabia
Doloage India
Dolodil India
Dololup India
Dolonex India
Dolopin India
Dupox India
Estcom India
Facicam Mexico
Felden Austria, Germany, Tunisia
Feldene Belgium, Brazil, Chile, Colombia, Ecuador, Egypt, Great Britain, Greece, Italy, Luxembourg, Morocco, Poland, Portugal, Romania, Saudi Arabia, Spain, United Arab Emirates, Venezuela
Feldoral Egypt
Flamalit Venezuela
Flexar Portugal
Flexase Germany
Flexicamin Argentina
Gecam India
Hotemin Hungary, Poland, Romania
Inflacam Egypt
Inflamase Greece
Inflax Brazil
Jenapirux Germany
Lopirox Iran
Neo Axedil Greece
Osteosam Colombia
Oximezin Greece
Oxivate Colombia
Panorox India
Pirocam Austria
Pirocutan Germany
Piroheum Germany, Hungary
Pirophlogont Germany
Pirosol Switzerland
Piroxen Tunisia
Piroxicam Belgium, Chile, Colombia, Ecuador, France, Germany, Italy, Peru, Venezuela
Piroxirar Egypt
Polipirox Italy
Pra Brexidol Germany
Proxigel Colombia
Pyrcost Greece
Riacen Morocco
Rocamix Iran
Romacam Iran
Rosiden Malaysia
Roxam Morocco, Tunisia
Roxene Italy
Roxicam Iran
Roxiden Italy
Solocalm Argentina
Stopen Colombia
Valopon Greece
Verand Colombia
Compatibility   injection   Compatibility : Piroxicam              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References

  Mentions Légales